Format

Send to:

Choose Destination
See comment in PubMed Commons below
Subcell Biochem. 2014;74:77-101. doi: 10.1007/978-94-007-7305-9_3.

A2 and other visceralizing proteins of Leishmania: role in pathogenesis and application for vaccine development.

Author information

  • 1Faculdade de Farmácia, Universidade Federal de Minas Gerais, Campus Pampulha, Av. Antônio Carlos 6627, Belo Horizonte, Minas Gerais, 31270901, Brazil, apfernandes.ufmg@gmail.com.

Abstract

Visceral leishmaniasis is a re-emergent disease and a significant cause of morbidity worldwide. Amongst the more than 20 Leishmania species, Leishmania donovani, Leishmania infantum and more rarely Leishmania amazonensis are associated with visceral leishmaniasis. A major question in leishmaniasis research is how these species migrate to and infect visceral organs whereas other species such as Leishmania major and Leishmania braziliensis remain in the skin, causing tegumentary leishmaniasis. Here we present the more recent advances and approaches towards the identification of species-specific visceralizing factors of Leishmania, such as the A2 protein, leading to a better understanding of parasite biology. We also discuss their potential use for the development of a vaccine for visceral leishmaniasis.

PMID:
24264241
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk